(VIANEWS) – Shares of NYXOAH (BEL 20: NYXH.BR) rose by a staggering 15.25% to €9.22 at 14:21 EST on Monday, after five sequential sessions in a row of gains. BEL 20 is jumping 0.14% to €3,843.40, after two successive sessions in a row of gains. This seems, as yet, a somewhat bullish trend trading session today.
NYXOAH’s last close was €8.00, 53.27% below its 52-week high of €17.12.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.22%.
Yearly Top and Bottom Value
NYXOAH’s stock is valued at €9.22 at 14:21 EST, way under its 52-week high of €17.12 and way above its 52-week low of €4.45.
Moving Average
NYXOAH’s value is way higher than its 50-day moving average of €5.66 and way above its 200-day moving average of €6.62.
Volatility
NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was 4.19%, 1.82%, and 2.32%.
NYXOAH’s highest amplitude of average volatility was 4.19% (last week), 2.94% (last month), and 2.32% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 26.9% and a negative 78.9%, respectively.
More news about NYXOAH (NYXH.BR).
